Knockdown of CCAT2 inhibited MCF-7 and MDA-MB-231 breast cancer cell proliferation and invasion in transwell migration assays by inhibiting WNT/β-catenin signaling [311]. This evidence concerns the gene CCAT2 and breast carcinoma.